Glaxosmithkline Pharmaceuticals is currently trading at Rs. 1695.40, up by 5.95 points or 0.35% from its previous closing of Rs. 1689.45 on the BSE.
The scrip opened at Rs. 1690.15 and has touched a high and low of Rs. 1710.00 and Rs. 1690.15 respectively. So far 1655 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1739.60 on 04-Dec-2023 and a 52 week low of Rs. 1228.00 on 03-May-2023.
Last one week high and low of the scrip stood at Rs. 1739.60 and Rs. 1671.00 respectively. The current market cap of the company is Rs. 28721.10 crore.
The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 12.52% and 12.49% respectively.
GlaxoSmithKline Pharmaceuticals has established an Omnichannel Team to expand its reach and coverage to the target segments by leveraging technology and improve productivity. Continuing its focus on improving operating efficiencies, the company has also completed the Voluntary Retirement Scheme (VRS) (for Commercial function employees in Field Sales and HO) and spent a sum of Rs 156.57 crore as the one-off cost of the VRS.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |